Skip to main content
. 2018 Apr 19;314(5):F934–F941. doi: 10.1152/ajprenal.00631.2017

Fig. 5.

Fig. 5.

A: NKCC2 activity in tubules perfused at 20 nl/min with and without 5 µmol/l NADPH oxidase (NOX) 1/4 specific inhibitor GKT-137831 (n = 6). B: NKCC2 activity in tubules perfused at 5 nl/min with and without 5 µmol/l NOX1/4 specific inhibitor GKT-137831 (n = 5).